GENEVA, Oct. 30 -- ALYSSUM THERAPEUTICS INC. filed a patent application (US2026/025036) for “A COMBINATION COMPRISING A TUBULIN INHIBITOR IN THE TREATMENT OF CANCER”. With publication no. WO/2026/226877, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/54
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....